Otsuka America Pharmaceutical

• NCT03063944

  Collaborator, Phase 1, Completed, 37 people, 24 Feb 2017

• NCT02183792

  Collaborator, Phase 4, Completed, 33 people, 8 Jul 2014

• NCT00665366

  Collaborator, Phase 3, Completed, 493 people, 23 Apr 2008

• NCT00448357

  Collaborator, Phase 1/2, Completed, 54 people, 16 Mar 2007

• The spectrum of bipolar disorder in older adults

  N/A, 22 Jan 2026

• Executive Function Among Older Adults With Bipolar Disorder: A GAGE-BD Analysis

  7 Dec 2025

Sources: pubmed.ncbi.nlm.nih.gov, api.crossref.org

• Indication-Specific Adverse Event Profiles of Semaglutide and Liraglutide: A FAERS Disproportionality Analysis

  ADA Scientific Sessions 2026 abstract, 6 Jun 2026

• Long-Term Effects of Metformin and Lifestyle Interventions on Ankle-Brachial Index in the Diabetes Prevention Program Outcomes Study (DPPOS)

  ADA Scientific Sessions 2026 abstract, 5 Jun 2026

• Diabetes Staging System (DSS)—A Novel Approach to Improve SGLT2i/GLP-1RA Use and CVD/CKD Outcomes in DM2

  ADA Scientific Sessions 2025 abstract, 13 Jun 2025